Effects of geranylgeranyltransferase Ⅰ gene silencing by RNA interference on the migration and invasion of tongue carcinoma

doi:10.7518/hxkq.2017.06.003

Abstract

Abstract:

Objective RNA interference was used to silence geranylgeranyltransferase Ⅰ(GGTase-Ⅰ) in vitro and to study the effect of GGTase-Ⅰ on the migration and invasion of tongue squamous cancer cells. Methods Three small interfering RNAs (siRNA) were designed according to the GGTase-Ⅰ sequence by Genebank and were transfected into tongue squamous cancer cells Cal-27 to knock down GGTase-Ⅰ expression. The tested cells were divided into three groups, as follows: the RNA-interfered groups (GGTase-Ⅰ siRNA1, GGTase-Ⅰ siRNA 2, GGTase-Ⅰ siRNA 3), a negative control group (disrupted by random sequence NC-siRNA), and a blank control group. GGTase-Ⅰ and RhoA gene expressions were examined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. The optimum interference group was screened by qRT-PCR and Western blot and was assigned as the experimental group. Matrix metalloproteinase (MMP)-2 and MMP-9 protein expressions were examined by Western blot. GTP-RhoA expression of protein was examined by GST-pull down. The migration and invasion abilities were analyzed by wound healing assay and Transwell motility assay. Results GGTase-Ⅰ mRNA and protein expression in Cal-27 decreased significantly after transfection of GGTase-I siRNA (P<0.05). No significant difference of RhoA gene expression was detected. MMP-2, MMP-9, and GTP-RhoA protein expressions decreased significantly (P<0.05). The migration and invasion abilities were inhibited (P<0.05). Conclusion To inhibit GGTase-Ⅰ expression, the migration and invasion abilities of tongue squa-mous cancer cells should also be inhibited. Further studies on GGTase-Ⅰ may provide novel effective molecular targets for tongue squamous cancer cells.

Key words: geranylgeranyltransferase Ⅰ, RhoA, tongue squamous cancer, migration, invasion, matrix metallo-proteinase-2, matrix metalloproteinase-9

CLC Number:

Zhenggang Chen, Shuren Wang, Jinghua Li, Jinhong Han, Qimin Wang, Lei Tong, Wenjun Liu, Fang Yang, Qingyuan Guo, Dawei Guo, Ying Wang. Effects of geranylgeranyltransferase Ⅰ gene silencing by RNA interference on the migration and invasion of tongue carcinoma[J]. West China Journal of Stomatology, 2017, 35(6): 576-582.

Figures/Tables 8

Tab 1

Fig 1

Fig 2

Fig 3

Fig 4

Fig 5

Fig 6

Fig 7

References 24

[1]	Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2007[J]. CA Cancer J Clin, 2007, 57(1):43-66.
[2]	Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2):74-108.
[3]	张陈平. 口腔癌临床及基础研究进展: 关于舌癌治疗的几点建议[J]. 中国实用口腔科杂志, 2010, 3(7):385-387.
	Zhang CP.Consideration of the treatment protocol for oral tongue cancer[J]. Chin J Pract Stomatol, 2010, 3(7):385-387.
[4]	Shen M, Pan P, Li Y, et al.Farnesyltransferase and geranyl geranyltransferaseⅠ: structures, mechanism, inhibitors and molecular modeling[J]. Drug Discov Today, 2015, 20(2):267-276.
[5]	Berndt N, Hamilton AD, Sebti SM.Targeting protein preny-lation for cancer therapy[J]. Nat Rev Cancer, 2011, 11(11):775-791.
[6]	Philips MR, Cox AD.GeranylgeranyltransferaseⅠas a tar-get for anti-cancer drugs[J]. J Clin Invest, 2007, 117(5):1223-1225.
[7]	Seabra MC, Reiss Y, Casey PJ, et al.Protein farnesyltrans-ferase and geranylgeranyltransferase share a common alpha subunit[J]. Cell, 1991, 65(3):429-434.
[8]	Khan OM, Akula MK, Skålen K, et al.Targeting GGTase-Ⅰactivates RHOA, increases macrophage reverse choles-terol transport, and reduces atherosclerosis in mice[J]. Cir-culation, 2013, 127(7):782-790.
[9]	Wang HB, Liu XP, Liang J, et al.Expression of RhoA and RhoC in colorectal carcinoma and its relations with clini-copathological parameters[J]. Clin Chem Lab Med, 2009, 47(7):811-817.
[10]	Kasuya K, Nagakawa Y, Hosokawa Y, et al.RhoA activity increases due to hypermethylation of ARHGAP28 in a highly liver-metastatic colon cancer cell line[J]. Biomed Rep, 2016, 4(3):335-339.
[11]	Cui J, Cai Y, Hu Y, et al.Epigenetic silencing of TPM2 con-tributes to colorectal cancer progression upon RhoA acti-vation[J]. Tumour Biol, 2016, 37(9):12477-12483.
[12]	Fujimura K, Choi S, Wyse M, et al.Eukaryotic translation initiation factor 5A (EIF5A) regulates pancreatic cancer metastasis by modulating RhoA and Rho-associated kinase (ROCK) protein expression levels[J]. J Biol Chem, 2015, 290(50):29907-29919.
[13]	Zhang C, Wu JM, Liao M, et al.The ROCK/GGTase path-way are essential to the proliferation and differentiation of neural stem cells mediated by simvastatin[J]. J Mol Neuro-sci, 2016, 60(4):474-485.
[14]	Leung KF, Baron R, Ali BR, et al.Rab GTPases containing a CAAX motif are processed post-geranylgeranylation by proteolysis and methylation[J]. J Biol Chem, 2007, 282(2): 1487-1497.
[15]	Aparna M, Rao L, Kunhikatta V, et al.The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2015, 44(5):345-352.
[16]	张明明, 徐玉清. MMP-2和MMP-9在恶性肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2012, 39(11):820-823.
	Zhang MM, Xu YQ.MMP-2 and MMP-9 in malignant tumor[J]. J Int Oncol, 2012, 39(11):820-823.
[17]	Björklund M, Koivunen E.Gelatinase-mediated migration and invasion of cancer cells[J]. Biochim Biophys Acta, 2005, 1755(1):37-69.
[18]	Song H, Cheng Y, Bi G, et al.Release of matrix metallopro-teinases-2 and 9 by S-nitrosylated caveolin-1 contributes to degradation of extracellular matrix in tPA-treated hypoxic endothelial cells[J]. PLoS One, 2016, 11(2):e0149269.
[19]	Chakrabarti S, Patel KD.Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology[J]. Exp Lung Res, 2005, 31(6):599-621.
[20]	Langers AM, Verspaget HW, Hawinkels LJ, et al.MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients[J]. Br J Cancer, 2012, 106(9):1495-1498.
[21]	Sullu Y, Demirag GG, Yildirim A, et al.Matrix metallo-proteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast[J]. Pathol Res Pract, 2011, 207(12):747-753.
[22]	González-Arriaga P, Pascual T, García-Alvarez A, et al.Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival[J]. BMC Cancer, 2012, 12: 121.
[23]	Kato K, Hara A, Kuno T, et al.Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity[J]. J Cancer Res Clin Oncol, 2005, 131(6):340-346.
[24]	陈正岗, 唐永平, 童磊, 等. 体外RNA干扰RhoA基因对舌癌细胞侵袭的影响[J]. 华西口腔医学杂志, 2016, 34(2):183-188.
	Chen ZG, Tang YP, Tong L, et al.Effects of RhoA gene silencing by RNA interference on invasion of tongue carci-noma[J]. West Chin J Stomatol, 2016, 34(2):183-188.

名称	产品编号	产品名称	靶序列
GGTase-Ⅰ siRNA1	siG000005229A	si-h-PGGT1B_001	GGAACAGCTCATCCTTATG
GGTase-Ⅰ siRNA2	siG000005229B	si-h-PGGT1B_002	CGACTTAAGCCGAGTAAAT
GGTase-Ⅰ siRNA3	siG000005229C	si-h-PGGT1B_003	GACTTCTGAACGCCTTCTA